Guillain-Barre syndrome


Guillain-Barre syndrome: Guillain-BarrC) syndrome (GBS) is the term used to describe a spectrum of rare post-infectious neuropathies that usually occur in otherwise healthy patients. GBS is clinically heterogeneous and encompasses acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome (MFS; see these terms) and some other regional variants.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 G61.0
Hospital discharge: ICD-9 3570
Hospital discharge: ICD-8 35401
Cause of death: ICD-10 G61.0
Cause of death: ICD-9 3570
Cause of death: ICD-8 35401


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9


diagram downward connector

Check minimum number of events None


diagram downward connector

Include endpoints None


diagram downward connector

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 G61
Name in latin Syndroma Guillain-Barré

Summary Statistics

Key figures

All Female Male
Number of individuals 329 153 176
Unadjusted prevalence (%) 0.11 0.09 0.13
Mean age at first event (years) 48.12 45.35 50.54


Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: G6_GUILBAR – Guillain-Barre syndrome
GWS hits: 0

Survival analyses between endpoints


before Guillain-Barre syndrome
after Guillain-Barre syndrome

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Guillain-Barre syndrome